New to Meducation?
Sign up
Already signed up? Log In
view moderators

MultipleSclerosis

Category

Preview
0
0

Health anxiety: the silent, disabling epidemic

“We are glad to say, Mr Jones, that all your test results are normal and you have nothing to fear.” Mr Jones has received this message many times after being examined for many severe diseases such as cancer, multiple sclerosis, and heart disease, which over the years he has been convinced he must have. Yet, this is the core of his problem—despite how much he would like to, he cannot do what the doctor says: stop worrying. He used to attend his general practitioner frequently to be reassured that nothing was wrong with him, but the reassurance was only short lived and then the worrying started all over again. After many years of distress, Mr Jones is embarrassed that he cannot control his health worries and preoccupation and has lately avoided contact with his GP, knowing it does not help him very much.  
feeds.bmj.com
over 4 years ago
Preview
0
0

Health anxiety: the silent, disabling epidemic

“We are glad to say, Mr Jones, that all your test results are normal and you have nothing to fear.” Mr Jones has received this message many times after being examined for many severe diseases such as cancer, multiple sclerosis, and heart disease, which over the years he has been convinced he must have. Yet, this is the core of his problem—despite how much he would like to, he cannot do what the doctor says: stop worrying. He used to attend his general practitioner frequently to be reassured that nothing was wrong with him, but the reassurance was only short lived and then the worrying started all over again. After many years of distress, Mr Jones is embarrassed that he cannot control his health worries and preoccupation and has lately avoided contact with his GP, knowing it does not help him very much.  
feeds.bmj.com
over 4 years ago
Preview
0
6

Prescribing sodium oxybate for narcolepsy

Narcolepsy affects around 4 in 10 000 people, making it about one quarter as common as multiple sclerosis in the United Kingdom.1 Its cardinal features are excessive daytime sleepiness causing frequent, irresistible naps; cataplexy, leading to collapse, embarrassment, and sometimes injury; and marked disturbance of nocturnal sleep. It is usually due to a specific deficiency of the hypothalamic neurotransmitter hypocretin and most often starts in the teens, probably as the result of an autoimmune process. Narcolepsy is far more than an occasional dose of sleepiness: it is a lifelong, pervasive, and potentially disabling disorder with a similar effect on quality of life to treatment resistant epilepsy.2  
feeds.bmj.com
over 4 years ago
Preview
0
6

Prescribing sodium oxybate for narcolepsy

Narcolepsy affects around 4 in 10 000 people, making it about one quarter as common as multiple sclerosis in the United Kingdom.1 Its cardinal features are excessive daytime sleepiness causing frequent, irresistible naps; cataplexy, leading to collapse, embarrassment, and sometimes injury; and marked disturbance of nocturnal sleep. It is usually due to a specific deficiency of the hypothalamic neurotransmitter hypocretin and most often starts in the teens, probably as the result of an autoimmune process. Narcolepsy is far more than an occasional dose of sleepiness: it is a lifelong, pervasive, and potentially disabling disorder with a similar effect on quality of life to treatment resistant epilepsy.2  
feeds.bmj.com
over 4 years ago
Preview
0
6

Prescribing sodium oxybate for narcolepsy

Narcolepsy affects around 4 in 10 000 people, making it about one quarter as common as multiple sclerosis in the United Kingdom.1 Its cardinal features are excessive daytime sleepiness causing frequent, irresistible naps; cataplexy, leading to collapse, embarrassment, and sometimes injury; and marked disturbance of nocturnal sleep. It is usually due to a specific deficiency of the hypothalamic neurotransmitter hypocretin and most often starts in the teens, probably as the result of an autoimmune process. Narcolepsy is far more than an occasional dose of sleepiness: it is a lifelong, pervasive, and potentially disabling disorder with a similar effect on quality of life to treatment resistant epilepsy.2  
feeds.bmj.com
over 4 years ago
Preview
0
6

From Vancouver, an Update on Multiple Sclerosis

Drs Krieger and Fox review some of the trends and outcomes in multiple sclerosis research at the American Academy of Neurology (AAN) 2016 Annual Meeting in Vancouver.  
medscape.com
over 4 years ago
Preview
0
6

EMA Panel Backs Daclizumab (Zinbryta) for Multiple Sclerosis

Daclizumab, a once-monthly injection, offers a targeted mechanism of action that is not expected to cause broad and prolonged immune cell depletion.  
medscape.com
over 4 years ago
Preview
0
6

Prenatal Vitamin D and Risk for Multiple Sclerosis

Dr Barclay discusses a study from Finland evaluating the risk for multiple sclerosis among children born to mothers with insufficient prenatal vitamin D levels.  
medscape.com
over 4 years ago
Preview
0
6

Should Rosacea Patients Be Screened for Autoimmune Diseases?

Dr Graeme Lipper reviews a population-based case-control study that explored the link between rosacea, type 1 diabetes, celiac disease, multiple sclerosis, and rheumatoid arthritis.  
medscape.com
over 4 years ago
Preview
0
6

Highlights of Key MS Data From the Annual 2016 Neurology Meeting CME

: Join our experts as they review the latest clinical trial data related to the management and treatment of multiple sclerosis.  
medscape.org
over 4 years ago
Preview
1
9

Multiple Sclerosis

Multiple sclerosis (MS) is a slowly progressive disease of the central nervous system. MS damages the protective covering of nerve fibers, which leads to mul...  
youtube.com
over 4 years ago
Preview
0
6

Perspectives on Key MS Data From the Annual Neurology Meeting CME

: Hear summaries of the most relevant research in multiple sclerosis that was presented at the 2016 American Academy of Neurology meeting.  
medscape.org
over 4 years ago
Preview
0
8

MS Highlights From the 2016 Annual Neurology Meeting CME

: Hear experts discuss new data on multiple sclerosis presented at the 2016 American Academy of Neurology meeting.  
medscape.org
over 4 years ago
Preview
0
8

Stem Cells, B Cells, and T Cells in Focus at CMSC

Presentations at the upcoming Consortium of Multiple Sclerosis Centers meeting will also shed light on working with patients using alternative treatments, such as medical marijuana and dietary supplements.  
medscape.com
over 4 years ago
Preview
0
6

FDA Approves Daclizumab (Zinbryta) for Multiple Sclerosis

The US Food and Drug Administration has approved daclizumab for treatment of patients with MS who are not responsive to other agents; the approval comes with a Risk Evaluation and Mitigation Strategy.  
medscape.com
over 4 years ago
Preview
0
6

Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting

Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting: Read clinically focused news coverage of key developments from CMSC 2016.  
medscape.com
over 4 years ago
Preview
0
6

Scientists discover an inherited gene for MS - BBC News

Scientists say they have found a gene that causes a rare but inherited form of multiple sclerosis.  
bbc.co.uk
over 4 years ago
Preview
0
10

Recent Achievements in Stem Cell-mediated Myelin Repair

Regeneration of myelin presents a promising approach for treating multiple sclerosis. What's the current state of research on the application of stem cell-mediated myelin repair?  
medscape.com
over 4 years ago
Preview
0
7

Young Men With MS at Higher Risk for Psychiatric Illness

Multiple sclerosis could act as a 'final trigger' in those who are susceptible to bipolar disorder and schizophrenia, researchers say.  
medscape.com
over 4 years ago
Preview
0
10

Treadmill Walking Improves Cognition in MS

A pilot study shows regular treadmill walking can improve cognition in multiple sclerosis. The researchers will conduct a larger randomized trial, to be funded by the National Institutes of Health.  
medscape.com
over 4 years ago